?
Læs mere om arbejdspladslogin her.

Content area

Videnskab / 27. nov 2017

Behandling af rolandisk epilepsi

Statusartikel
Dato
27. nov 2017
Forfattere
Maria J. Miranda1 & Banoo Bakir Ahmad2 1) Børne- og Ungeafdelingen, Herlev Hospital 2) Panum Instituttet, Det Sundhedsvidenskabelige Fakultet, Københavns Universitet Ugeskr Læger 2017;179:V06170482
💬 0
Reference: 
Ugeskr Læger 2017;179:V06170482
Blad nummer: 
Sidetal: 
2-7
Treatment of rolandic epilepsy
Recent literature indicates, that rolandic epilepsy/epilepsy of childhood with centrotemporal spikes may not be as benign as previously assumed. This study investigates the existing evidence, which describes the treatment effects on seizure frequency as well as improvement of cognition in children with rolandic epilepsy. We conclude, that treatment with anti-epileptic drugs could be justified, if treatment reduces seizures, prevents the evolution to atypical forms, or diminishes the negative cognitive consequences associated with the disease. Levetiracetam and sulthiame are the recommended treatments according to the existing evidence, which is still insufficient. A larger randomized controlled trial is warranted.

💬 0 Kommentarer

Du skal være logget ind for at læse denne artikel
Log ind

Du kan også købe adgang

Køb abonnement til Ugeskriftet.dk (der er forskellige abonnementstyper )

Right side

Nr. 25/2017

Senest kommenteret

Åndelig omsorg er et nyt forskningsfelt
💬
1
Torben Andersen 11. dec 2017 16:54
Har Danske Regioner scoret et selvmål?
💬
2
Annette Dam Fialla 11. dec 2017 10:07
OUH-ledelse siger undskyld til kritisk læge
💬
6
Niels Kristian Kjær 4. dec 2017 22:36